Clinical trial
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With…
NCT00022191 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00022191 |
|---|---|
| Title | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer |
| Official title | Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients With Metastatic or Locally Advanced Urothelial Cancer Without Prior Systemic Therapy |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Collaborators | National Cancer Institute (NCI) NIH Groupe D'Etude des Tumeurs Uro-Genitales Institute of Cancer Research, United Kingdom Central European Cooperative Oncology Group NCIC Clinical Trials Group SWOG… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, gemcitabine hydrochloride, paclitaxel |
| Enrollment | 608 |
| Start date | May 1, 2001 |
| Primary completion | Jun 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 12, 2013 |
| Countries | Australia, Austria, Belgium, Canada, Denmark, France, Germany, Hungary, Israel, Italy, Netherlands, Poland and 4 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: